https://www.selleckchem.com/pr....oducts/-epicatechin.
431, P=0.185, respectively). Similarly, the multivariate analysis model showed no association between the administration of parecoxib and RFS [hazard ratio (HR), 0.964; 95% confidence interval (CI), 0.599-1.551, P=0.878] or OS (HR, 1.043; 95% CI, 0.621-1.750; P=0.875). In these patients, elevated preoperative neutrophil-lymphocyte ratio (NLR) was demonstrated to be associated with RFS and OS. CONCLUSIONS The present study found that intraoperative parecoxib use was not associated with improved outcome after BCa surgery. Prospective
Like
Comment
Share
